| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0042 | 0.9 |